{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:23:22Z","timestamp":1792664602331,"version":"4.5.0"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023674","name":"King Khalid University Deanship of Scientific Research","doi-asserted-by":"publisher","award":["RGP2\/312\/45"],"award-info":[{"award-number":["RGP2\/312\/45"]}],"id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.tice.2024.102679","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T16:25:41Z","timestamp":1734020741000},"page":"102679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Heterogeneity of modulatory immune microenvironment in bladder cancer"],"prefix":"10.1016","volume":"93","author":[{"given":"Enas","family":"El Saftawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma Emad","family":"Aboulhoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour A.","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa Ali","family":"Abd Elkhalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nashwah Samir","family":"AlHariry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"181","key":"10.1016\/j.tice.2024.102679_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.24976\/Discov.Med.202436181.21","article-title":"Microbiota-parasite interaction: implication of secretory immunoglobulin A and P2X7 receptor signaling","volume":"36","author":"Aboulhoda","year":"2024","journal-title":"Discov. Med."},{"key":"10.1016\/j.tice.2024.102679_bib2","article-title":"High CD14 antigen expression in urothelial bladder carcinoma establishes that the inflammatory microenvironment promotes tumour cell proliferation","volume":"18","author":"Ahmad","year":"2022","journal-title":"Malays. J. Med. Health Sci."},{"issue":"1","key":"10.1016\/j.tice.2024.102679_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-36709-1","article-title":"Urogenital schistosomiasis is associated with signatures of microbiome dysbiosis in Nigerian adolescents","volume":"9","author":"Ajibola","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.tice.2024.102679_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrurol.2015.292","article-title":"The interplay of extracellular matrix and microbiome in urothelial bladder cancer","volume":"13","author":"Alfano","year":"2016","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.tice.2024.102679_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2024.102416","article-title":"Comparison of tissue biomarkers between non-schistosoma and schistosoma-associated urothelial carcinoma","author":"AlHariry","year":"2024","journal-title":"Tissue Cell"},{"key":"10.1016\/j.tice.2024.102679_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175678","article-title":"TGF-\u03b2 signaling pathway: therapeutic targeting and potential for anti-cancer immunity.","author":"Ali","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tice.2024.102679_bib7","article-title":"Natural killer cell subsets in tumor draining lymph nodes of patients with bladder cancer and their clinical implications","author":"Ariafar","year":"2024","journal-title":"Iran. J. Immunol."},{"issue":"1","key":"10.1016\/j.tice.2024.102679_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/medicina56010015","article-title":"Tumor microenvironment","volume":"56","author":"Arneth","year":"2019","journal-title":"Medicina"},{"key":"10.1016\/j.tice.2024.102679_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173226","article-title":"PTEN: What we know of the function and regulation of this onco-suppressor factor in bladder cancer?","volume":"881","author":"Ashrafizadeh","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.tice.2024.102679_bib10","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s00109-020-01973-0","article-title":"Relevance of iNOS expression in tumor growth and maintenance of cancer stem cells in a bladder cancer model","volume":"98","author":"Belgorosky","year":"2020","journal-title":"J. Mol. Med."},{"issue":"10","key":"10.1016\/j.tice.2024.102679_bib11","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1099\/jmm.0.001058","article-title":"Urinary microbiota\u2013a potential biomarker and therapeutic target for bladder cancer.","volume":"68","author":"Bi","year":"2019","journal-title":"J. Med. Microbiol."},{"issue":"11","key":"10.1016\/j.tice.2024.102679_bib12","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.trecan.2018.09.001","article-title":"The role of type 1 conventional dendritic cells in cancer immunity","volume":"4","author":"B\u00f6ttcher","year":"2018","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.tice.2024.102679_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41423-021-00734-4","article-title":"CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies","volume":"19","author":"Bullock","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"4","key":"10.1016\/j.tice.2024.102679_bib14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/UROS.UROS_26_22","article-title":"Comparing concentration of urinary inflammatory cytokines in interstitial cystitis, overactive bladder, urinary tract infection, and bladder cancer","volume":"33","author":"Chancellor","year":"2022","journal-title":"Urol. Sci."},{"issue":"15","key":"10.1016\/j.tice.2024.102679_bib15","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1073\/pnas.1424795112","article-title":"CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer","volume":"112","author":"Cheah","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.tice.2024.102679_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108597","article-title":"Cancer stemness meets immunity: from mechanism to therapy","volume":"34","author":"Chen","year":"2021","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.tice.2024.102679_bib17","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1158\/1078-0432.CCR-18-1656","article-title":"Long noncoding RNA LBCS inhibits self-renewal and chemoresistance of bladder cancer stem cells through epigenetic silencing of SOX2","volume":"25","author":"Chen","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.tice.2024.102679_bib18","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ymthe.2018.12.015","article-title":"DANCR promotes metastasis and proliferation in bladder cancer cells by enhancing IL-11-STAT3 signaling and CCND1 expression","volume":"27","author":"Chen","year":"2019","journal-title":"Mol. Ther."},{"issue":"9","key":"10.1016\/j.tice.2024.102679_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.685","article-title":"Oncogenic SLC2A11\u2013MIF fusion protein interacts with polypyrimidine tract binding protein 1 to facilitate bladder cancer proliferation and metastasis by regulating mRNA stability","volume":"5","author":"Cheng","year":"2024","journal-title":"MedComm"},{"issue":"8","key":"10.1016\/j.tice.2024.102679_bib20","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1172\/JCI89717","article-title":"ILC2-modulated T cell\u2013to-MDSC balance is associated with bladder cancer recurrence","volume":"127","author":"Chevalier","year":"2017","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.tice.2024.102679_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijrobp.2022.06.054","article-title":"Tumor-derived CC motif ligand 2 induces the recruitment and polarization of tumor-associated macrophages and increases the metastatic potential of bladder cancer cells in the postirradiated microenvironment","volume":"114","author":"Chiang","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"12","key":"10.1016\/j.tice.2024.102679_bib22","doi-asserted-by":"crossref","first-page":"922","DOI":"10.7326\/M15-0997","article-title":"Urinary biomarkers for diagnosis of bladder cancer: a systematic review and meta-analysis","volume":"163","author":"Chou","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tice.2024.102679_bib23","unstructured":"Chung, W.M., Molony, R.D., & Lee, Y.F. (2021). Non-stem bladder cancer cell-derived extracellular vesicles promote."},{"issue":"3","key":"10.1016\/j.tice.2024.102679_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.24920\/004340","article-title":"UBE2C as an immune-related biomarker for breast cancer: a study based on multiple databases","volume":"39","author":"Cui","year":"2024","journal-title":"Chin. Med. Sci. J."},{"issue":"39","key":"10.1016\/j.tice.2024.102679_bib25","doi-asserted-by":"crossref","first-page":"8203","DOI":"10.2174\/0929867328666210720143721","article-title":"The role of tumor associated macrophages (TAMs) in cancer progression, chemoresistance, angiogenesis and metastasis-current status","volume":"28","author":"Dallavalasa","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.tice.2024.102679_bib26","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s12885-022-09616-y","article-title":"A novel and sensitive DNA methylation marker for the urine-based liquid biopsies to detect bladder cancer","volume":"22","author":"Deng","year":"2022","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.tice.2024.102679_bib27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13287-022-02829-9","article-title":"Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy","volume":"13","author":"Dianat-Moghadam","year":"2022","journal-title":"Stem Cell Res. Ther."},{"issue":"2","key":"10.1016\/j.tice.2024.102679_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tranon.2019.10.018","article-title":"Checkpoint genes at the cancer side of the immunological synapse in bladder cancer","volume":"13","author":"Dobosz","year":"2020","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.tice.2024.102679_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.fawpar.2023.e00201","article-title":"Effects of Lactobacilli acidophilus and\/or spiramycin as an adjunct in toxoplasmosis infection challenged with diabetes","volume":"32","author":"El Saftawy","year":"2023","journal-title":"Food Waterborne Parasitol."},{"issue":"2","key":"10.1016\/j.tice.2024.102679_bib30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/0394632015584733","article-title":"Immunohistochemical pattern of T lymphocytes population within bilharzial-associated bladder neoplasm microenvironment","volume":"28","author":"El-Aal","year":"2015","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"1","key":"10.1016\/j.tice.2024.102679_bib31","first-page":"11","article-title":"Tumour-associated macrophages (IL-23+ CD14+ subset) levels during bladder cancer progression","volume":"2","author":"El-Gedamy","year":"2021","journal-title":"Front. Sci. Res. Technol."},{"issue":"2","key":"10.1016\/j.tice.2024.102679_bib32","first-page":"133","article-title":"Conceptions in parasite-microbiota relationships","volume":"14","author":"Elsaftawy","year":"2021","journal-title":"Parasitol. U. J."},{"key":"10.1016\/j.tice.2024.102679_bib33","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1245\/s10434-019-07371-2","article-title":"A combination of positive tumor HLA-I and negative PD-L1 expression provides an immune rejection mechanism in bladder cancer","volume":"26","author":"Flores-Mart\u00edn","year":"2019","journal-title":"Ann. Surg. Oncol."},{"issue":"24","key":"10.1016\/j.tice.2024.102679_bib34","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.2217\/fon-2021-0273","article-title":"Perioperative pembrolizumab therapy in muscle-invasive bladder cancer: phase III KEYNOTE-866 and KEYNOTE-905\/EV-303","volume":"17","author":"Galsky","year":"2021","journal-title":"Future Oncol."},{"key":"10.1016\/j.tice.2024.102679_bib35","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2147\/OTT.S237127","article-title":"Nucleolar and spindle associated protein 1 (NUSAP1) promotes bladder cancer progression through the TGF-\u03b2 signaling pathway","author":"Gao","year":"2020","journal-title":"OncoTargets Ther."},{"issue":"2","key":"10.1016\/j.tice.2024.102679_bib36","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3892\/ijo.2015.3041","article-title":"CXCL5\/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K\/AKT-induced upregulation of MMP2\/MMP9","volume":"47","author":"Gao","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.tice.2024.102679_bib37","first-page":"284","article-title":"NKG2D is a key receptor for recognition of bladder cancer cells by IL-2-activated NK cells and BCG promotes NK cell activation","volume":"6","author":"Garc\u00eda-Cuesta","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tice.2024.102679_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5353-6","article-title":"Cancer-associated fibroblasts induce epithelial\u2013mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling","volume":"19","author":"Goulet","year":"2019","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.tice.2024.102679_bib39","first-page":"113","article-title":"New insights in bladder cancer diagnosis: urinary miRNAs and proteins","volume":"6","author":"G\u00fcll\u00fc Amuran","year":"2018","journal-title":"Med. Sci."},{"issue":"7","key":"10.1016\/j.tice.2024.102679_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200079","article-title":"Urothelial bladder cancer may suppress perforin expression in CD8+ T cells by an ICAM-1\/TGF\u03b22 mediated pathway","volume":"13","author":"Hartana","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.tice.2024.102679_bib41","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-3-030-59038-3_17","article-title":"The tumor microenvironment of bladder cancer","author":"Hatogai","year":"2020","journal-title":"Tumor Microenvironments in Organs: From the Brain to the Skin\u2013Part B"},{"issue":"10_Supplement","key":"10.1016\/j.tice.2024.102679_bib42","doi-asserted-by":"crossref","DOI":"10.1158\/1557-3265.BLADDER24-IA007","article-title":"Abstract IA007: Tumor HLA-E expression and cytomegalovirus infection modulate NK cell activity in human bladder cancer","volume":"30","author":"Horowitz","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.tice.2024.102679_bib43","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.21873\/anticanres.14243","article-title":"Tumor-associated macrophages facilitate bladder cancer progression by increasing cell growth, migration, invasion and cytokine expression","volume":"40","author":"Huang","year":"2020","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.tice.2024.102679_bib44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/cac2.12284","article-title":"HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5-WDR5-dependent transcriptional program","volume":"42","author":"Huang","year":"2022","journal-title":"Cancer Commun."},{"issue":"5","key":"10.1016\/j.tice.2024.102679_bib45","first-page":"1555","article-title":"Bladder cancer cells interact with vascular endothelial cells triggering EGFR signals to promote tumor progression","volume":"54","author":"Huang","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"23","key":"10.1016\/j.tice.2024.102679_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315177","article-title":"miR-221-5p and miR-186-5p are the critical bladder cancer derived exosomal miRNAs in natural killer cell dysfunction","volume":"23","author":"Huyan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2024.102679_bib47","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s11033-018-4221-9","article-title":"KIRs gene content diversity in Iranians with urothelial bladder cancer","volume":"45","author":"Jamali","year":"2018","journal-title":"Mol. Biol. Rep."},{"issue":"7","key":"10.1016\/j.tice.2024.102679_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254433","article-title":"Prognostic value of circulating tumor cells in patients with bladder cancer: a meta-analysis","volume":"16","author":"Jiang","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.tice.2024.102679_bib49","article-title":"MiR-30a: a novel biomarker and potential therapeutic target for cancer.","volume":"2018","author":"Jiang","year":"2018","journal-title":"J. Oncol."},{"key":"10.1016\/j.tice.2024.102679_bib50","article-title":"PD-1-positive tumor-associated macrophages define poor clinical outcomes in patients with muscle invasive bladder cancer through potential CD68\/PD-1 complex interactions","volume":"11","author":"Jiang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tice.2024.102679_bib51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00262-018-2250-9","article-title":"CD19+ tumor-infiltrating B-cells prime CD4+ T-cell immunity and predict platinum-based chemotherapy efficacy in muscle-invasive bladder cancer","volume":"68","author":"Jiang","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.tice.2024.102679_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.930352","article-title":"Identification of a six-gene prognostic signature for bladder cancer associated macrophage","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tice.2024.102679_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-020-07548-z","article-title":"Bladder cancer-derived interleukin-1 converts the vascular endothelium into a pro-inflammatory and pro-coagulatory surface","volume":"20","author":"John","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tice.2024.102679_bib54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.12659\/MSMBR.902285","article-title":"M3 macrophages stop division of tumor cells in vitro and extend survival of mice with ehrlich ascites carcinoma","volume":"23","author":"Kalish","year":"2017","journal-title":"Med. Sci. Monit. Basic Res."},{"issue":"36","key":"10.1016\/j.tice.2024.102679_bib55","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.11277","article-title":"UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria","volume":"7","author":"Kim","year":"2016","journal-title":"Oncotarget"},{"issue":"16","key":"10.1016\/j.tice.2024.102679_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169148","article-title":"Diagnostic potential of circulating tumor cells, urinary microRNA, and urinary cell-free DNA for bladder cancer: a review","volume":"23","author":"Koguchi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.tice.2024.102679_bib57","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12943-023-01897-6","article-title":"The impact of FGFR3 alterations on the tumor microenvironment and the efficacy of immune checkpoint inhibitors in bladder cancer","volume":"22","author":"Komura","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tice.2024.102679_bib58","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.canlet.2020.06.018","article-title":"Targeting Stat3 signaling impairs the progression of bladder cancer in a mouse model","volume":"490","author":"Korac-Prlic","year":"2020","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.tice.2024.102679_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25084365","article-title":"The clinical significance and involvement in molecular cancer processes of chemokine CXCL1 in selected tumors","volume":"25","author":"Korbecki","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.tice.2024.102679_bib60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.tice.2024.102679_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082321","article-title":"P2X1 and P2X7 receptor overexpression is a negative predictor of survival in muscle-invasive bladder cancer","volume":"15","author":"Ledderose","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.tice.2024.102679_bib62","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000486908","article-title":"BDNF VAL66MET polymorphism elevates the risk of bladder cancer via MiRNA-146b in Micro-Vehicles","volume":"45","author":"Li","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.tice.2024.102679_bib63","article-title":"Identification of endothelial-related molecular subtypes for bladder cancer patients","volume":"13","author":"Li","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tice.2024.102679_bib64","doi-asserted-by":"crossref","DOI":"10.1152\/physiolgenomics.00032.2024","article-title":"Microbiota-induced inflammatory responses in bladder tumors promote epithelial-mesenchymal transition and enhanced immune infiltration","author":"Li","year":"2024","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.tice.2024.102679_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12894-021-00938-w","article-title":"Identification of prognostic and therapeutic value of CC chemokines in Urothelial bladder cancer: evidence from comprehensive bioinformatic analysis","volume":"21","author":"Li","year":"2021","journal-title":"BMC Urol."},{"key":"10.1016\/j.tice.2024.102679_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.615091","article-title":"Immunological hallmarks for clinical response to BCG in bladder cancer","volume":"11","author":"Lim","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.tice.2024.102679_bib67","first-page":"151","article-title":"Bladder cancer cell-secreted exosomal miR-21 activates the PI3K\/AKT pathway in macrophages to promote cancer progression","volume":"56","author":"Lin","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.tice.2024.102679_bib68","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3389\/fonc.2020.00589","article-title":"Downregulation of HMGA1 mediates autophagy and inhibits migration and invasion in bladder cancer via miRNA-221\/TP53INP1\/p-ERK Axis","volume":"10","author":"Liu","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tice.2024.102679_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12865-016-0174-8","article-title":"Immune analysis of expression of IL-17 relative ligands and their receptors in bladder cancer: comparison with polyp and cystitis","volume":"17","author":"Liu","year":"2016","journal-title":"BMC Immunol."},{"issue":"9","key":"10.1016\/j.tice.2024.102679_bib70","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1474317","article-title":"Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle-invasive bladder cancer","volume":"7","author":"Liu","year":"2018","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.tice.2024.102679_bib71","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/cancers13010131","article-title":"Immune checkpoint inhibitors for the treatment of bladder cancer","volume":"13","author":"Lopez-Beltran","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.tice.2024.102679_bib72","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mc.23663","article-title":"SPI1-mediated CXCL12 expression in bladder cancer affects the recruitment of tumor-associated macrophages","volume":"63","author":"Lu","year":"2024","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.tice.2024.102679_bib73","article-title":"Identifying a novel defined pyroptosis-associated long noncoding RNA signature contributes to predicting prognosis and tumor microenvironment of bladder cancer","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tice.2024.102679_bib74","doi-asserted-by":"crossref","DOI":"10.59717\/j.xinn-med.2024.100094","article-title":"Crosstalk between bladder cancer and the tumor microenvironment: molecular mechanisms and targeted therapy","author":"Lu","year":"2024","journal-title":"Innov. Med."},{"issue":"6","key":"10.1016\/j.tice.2024.102679_bib75","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.gendis.2022.05.020","article-title":"A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9)","volume":"10","author":"Lv","year":"2023","journal-title":"Genes Dis."},{"issue":"5","key":"10.1016\/j.tice.2024.102679_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054760","article-title":"Crosstalk between mesenchymal stem cells and cancer stem cells reveals a novel stemness-related signature to predict prognosis and immunotherapy responses for bladder cancer patients","volume":"24","author":"Ma","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.tice.2024.102679_bib77","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3390\/biomedicines10020411","article-title":"Immune-checkpoint inhibitors in advanced bladder cancer: seize the day","volume":"10","author":"Maiorano","year":"2022","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.tice.2024.102679_bib78","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3390\/cells9020291","article-title":"Tumor-infiltrating neutrophils are enriched in basal-type urothelial bladder cancer","volume":"9","author":"Mandelli","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.tice.2024.102679_bib79","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13045-021-01085-3","article-title":"Immunotherapies targeting stimulatory pathways and beyond","volume":"14","author":"Marin-Acevedo","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"23","key":"10.1016\/j.tice.2024.102679_bib80","doi-asserted-by":"crossref","first-page":"7388","DOI":"10.1158\/1078-0432.CCR-17-1004","article-title":"BMP4 induces M2 macrophage polarization and favors tumor progression in bladder cancer","volume":"23","author":"Mart\u00ednez","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tice.2024.102679_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.1070383","article-title":"Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: cytokines in the game?","volume":"9","author":"Martins-Lima","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.tice.2024.102679_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01146","article-title":"Tumor associated neutrophils. Their role in tumorigenesis, metastasis, prognosis and therapy","volume":"9","author":"Masucci","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tice.2024.102679_bib83","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clim.2016.01.008","article-title":"Roles of CD48 in regulating immunity and tolerance","volume":"164","author":"McArdel","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.tice.2024.102679_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119948","article-title":"Long non-coding RNAs as new players in bladder cancer: lessons from pre-clinical and clinical studies","volume":"288","author":"Mirzaei","year":"2022","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.tice.2024.102679_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102186","article-title":"Regulatory T cells and tumor-associated macrophages in the tumor microenvironment in non-muscle invasive bladder cancer treated with intravesical Bacille Calmette-Gu\u00e9rin: a long-term follow-up study of a Japanese cohort","volume":"18","author":"Miyake","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.tice.2024.102679_bib86","doi-asserted-by":"crossref","first-page":"8970","DOI":"10.1002\/cam4.5579","article-title":"KLRF1, a novel marker of CD56bright NK cells, predicts improved survival for patients with locally advanced bladder cancer","volume":"12","author":"Mukherjee","year":"2023","journal-title":"Cancer Med."},{"issue":"4","key":"10.1016\/j.tice.2024.102679_bib87","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.ucl.2020.10.005","article-title":"The tumor microenvironment and immunotherapy in prostate and bladder cancer","volume":"47","author":"Nair","year":"2020","journal-title":"Urol. Clin. North Am."},{"issue":"28","key":"10.1016\/j.tice.2024.102679_bib88","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.4569","article-title":"Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8\/androgen receptor (AR)\/MMPs signals","volume":"6","author":"Ou","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.tice.2024.102679_bib89","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3389\/fonc.2019.00613","article-title":"Identification of biomarkers for controlling cancer stem cell characteristics in bladder cancer by network analysis of transcriptome data stemness indices","volume":"9","author":"Pan","year":"2019","journal-title":"Front. Oncol."},{"issue":"15","key":"10.1016\/j.tice.2024.102679_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512311","article-title":"The bladder tumor microenvironment components that modulate the tumor and impact therapy","volume":"24","author":"Patwardhan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2024.102679_bib91","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00262-019-02429-2","article-title":"Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response","volume":"68","author":"Qi","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.tice.2024.102679_bib92","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2147\/CMAR.S223172","article-title":"LncRNA NCK1-AS1 promotes cancer cell proliferation and increase cell stemness in urinary bladder cancer patients by downregulating miR-143","author":"Qiao","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.tice.2024.102679_bib93","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fgene.2020.00012","article-title":"Identification and validation of an individualized prognostic signature of bladder cancer based on seven immune related genes","volume":"11","author":"Qiu","year":"2020","journal-title":"Front. Genet."},{"issue":"7","key":"10.1016\/j.tice.2024.102679_bib94","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.5467","article-title":"Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ER\u03b2\/CCL2\/CCR2 EMT\/MMP9 signals","volume":"7","author":"Rao","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.tice.2024.102679_bib95","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","article-title":"The global burden of urinary bladder cancer: an update","volume":"38","author":"Richters","year":"2020","journal-title":"World J. Urol."},{"issue":"3","key":"10.1016\/j.tice.2024.102679_bib96","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00262-022-03250-0","article-title":"A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer","volume":"72","author":"Rijnders","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"9","key":"10.1016\/j.tice.2024.102679_bib97","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.ccell.2022.08.005","article-title":"NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer","volume":"40","author":"Salom\u00e9","year":"2022","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.tice.2024.102679_bib98","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/stem.2406","article-title":"Concise review: stem cells and epithelial-mesenchymal transition in cancer: biological implications and therapeutic targets","volume":"34","author":"Sato","year":"2016","journal-title":"Stem Cells"},{"issue":"10","key":"10.1016\/j.tice.2024.102679_bib99","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41585-019-0226-y","article-title":"The multifaceted immune regulation of bladder cancer","volume":"16","author":"Schneider","year":"2019","journal-title":"Nat. Rev. Urol."},{"issue":"4","key":"10.1016\/j.tice.2024.102679_bib100","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/j.clgc.2015.02.001","article-title":"Neutrophil-lymphocyte ratio and pathological response to neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer","volume":"13","author":"Seah","year":"2015","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.tice.2024.102679_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105880","article-title":"A review on the role of M2 macrophages in bladder cancer; pathophysiology and targeting","volume":"76","author":"Sharifi","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.tice.2024.102679_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.109932","article-title":"LINC01451 drives epithelial-mesenchymal transition and progression in bladder cancer cells via LIN28\/TGF-\u03b2\/Smad pathway.","volume":"81","author":"Shi","year":"2021","journal-title":"Cell. Signal."},{"issue":"6","key":"10.1016\/j.tice.2024.102679_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063105","article-title":"Strategies for overcoming immune evasion in bladder cancer","volume":"25","author":"Shin","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2024.102679_bib104","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12307-017-0199-4","article-title":"Positive correlation between matrix metalloproteinases and epithelial-to-mesenchymal transition and its association with clinical outcome in bladder cancer patients","volume":"11","author":"Singh","year":"2018","journal-title":"Cancer Microenviron."},{"issue":"3","key":"10.1016\/j.tice.2024.102679_bib105","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/cpt.1964","article-title":"PK\/PD mediated dose optimization of emactuzumab, a CSF1R inhibitor, in patients with advanced solid tumors and diffuse-type tenosynovial giant cell tumor","volume":"108","author":"Smart","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.tice.2024.102679_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25126325","article-title":"Prognostic and predictive potential of CCL5 expression in muscle-invasive bladder cancer patients","volume":"25","author":"Smolka","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"54","key":"10.1016\/j.tice.2024.102679_bib107","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.21565","article-title":"Inflammatory microenvironment in the initiation and progression of bladder cancer","volume":"8","author":"Sui","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tice.2024.102679_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.724107","article-title":"A transcriptional signature of IL-2 expanded natural killer cells predicts more favorable prognosis in bladder cancer","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tice.2024.102679_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-020-01973-4","article-title":"Development and validation of a novel stem cell subtype for bladder cancer based on stem genomic profiling","volume":"11","author":"Tang","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.tice.2024.102679_bib110","first-page":"1","article-title":"Immune checkpoints in the tumor microenvironment","volume":"65","author":"Toor","year":"2020"},{"key":"10.1016\/j.tice.2024.102679_bib111","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.reth.2021.02.006","article-title":"Immune evasion by cancer stem cells","volume":"17","author":"Tsuchiya","year":"2021","journal-title":"Regen. Ther."},{"key":"10.1016\/j.tice.2024.102679_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1235884","article-title":"The bladder cancer immune micro-environment in the context of response to immune checkpoint inhibition","volume":"14","author":"van Dorp","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tice.2024.102679_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103032","article-title":"Which type of cancer patients are more susceptible to the SARS-COX-2: evidence from a meta-analysis and bioinformatics analysis","volume":"153","author":"Wang","year":"2020","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"1","key":"10.1016\/j.tice.2024.102679_bib114","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13046-024-02955-7","article-title":"High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor","volume":"43","author":"Wang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.tice.2024.102679_bib115","doi-asserted-by":"crossref","first-page":"10203","DOI":"10.1007\/s00432-023-04867-z","article-title":"High risk of non-cancer mortality in bladder cancer patients: evidence from SEER-Medicaid","volume":"149","author":"Wang","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.tice.2024.102679_bib116","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1111\/jcmm.15480","article-title":"A SNP of miR-146a is involved in bladder cancer relapse by affecting the function of bladder cancer stem cells via the miR-146a signallings.","volume":"24","author":"Wang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.tice.2024.102679_bib117","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s40249-024-01233-0","article-title":"Prevalence and correlations of schistosomiasis mansoni and schistosomiasis haematobium among humans and intermediate snail hosts: a systematic review and meta-analysis","volume":"13","author":"Wang","year":"2024","journal-title":"Infect. Dis. Poverty"},{"issue":"5","key":"10.1016\/j.tice.2024.102679_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23754","article-title":"A combination of ssGSEA and mass cytometry identifies immune microenvironment in muscle-invasive bladder cancer.","volume":"35","author":"Wang","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"issue":"2","key":"10.1016\/j.tice.2024.102679_bib119","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.18632\/aging.202247","article-title":"Silencing LINC00482 inhibits tumor-associated inflammation and angiogenesis through down-regulation of MMP-15 via FOXA1 in bladder cancer","volume":"13","author":"Wang","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.tice.2024.102679_bib120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.euo.2022.03.005","article-title":"Highly sensitive and specific detection of bladder cancer via targeted ultra-deep sequencing of urinary DNA","volume":"6","author":"Ward","year":"2023","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.tice.2024.102679_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104254","article-title":"IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy","volume":"359","author":"Weber","year":"2021","journal-title":"Cell. Immunol."},{"issue":"8","key":"10.1016\/j.tice.2024.102679_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2016.e00143","article-title":"Intra-tumour IgA1 is common in cancer and is correlated with poor prognosis in bladder cancer","volume":"2","author":"Welinder","year":"2016","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.tice.2024.102679_bib123","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2208697","article-title":"Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors","volume":"15","author":"Whalen","year":"2023","journal-title":"MAbs"},{"issue":"8","key":"10.1016\/j.tice.2024.102679_bib124","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1002\/ijc.33359","article-title":"Recurrent bladder cancer in aging societies: Importance of major histocompatibility complex class I antigen presentation","volume":"148","author":"Wieczorek","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.tice.2024.102679_bib125","first-page":"547","article-title":"The role of matrix metalloproteinases in pathogenesis of human bladder cancer","volume":"68","author":"Wi\u015bniowski","year":"2021","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.tice.2024.102679_bib126","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fcimb.2018.00167","article-title":"Profiling the urinary microbiota in male patients with bladder cancer in China","volume":"8","author":"Wu","year":"2018","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"6","key":"10.1016\/j.tice.2024.102679_bib127","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1303","article-title":"PD1hi CD200hi CD4+ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial\u2013mesenchymal transition in bladder cancer","volume":"13","author":"Wu","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.tice.2024.102679_bib128","article-title":"Tumour-associated macrophages mediate the invasion and metastasis of bladder cancer cells through CXCL8","volume":"8","author":"Wu","year":"2020","journal-title":"PeerJ"},{"issue":"4","key":"10.1016\/j.tice.2024.102679_bib129","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1158\/0008-5472.CAN-21-0403","article-title":"PKM2 is essential for bladder cancer growth and maintenance","volume":"82","author":"Xia","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.tice.2024.102679_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tice.2024.102679_bib131","first-page":"1","article-title":"CXCL9 secreted by tumor-associated dendritic cells up-regulates PD-L1 expression in bladder cancer cells by activating the CXCR3 signaling","volume":"22","author":"Xiu","year":"2021","journal-title":"BMC Immunol."},{"issue":"39","key":"10.1016\/j.tice.2024.102679_bib132","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.11434","article-title":"Immunosuppressive effect of bladder cancer on function of dendritic cells involving of Jak2\/STAT3 pathway","volume":"7","author":"Xiu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.tice.2024.102679_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.106976","article-title":"FGFR3 mutation characterization identifies prognostic and immune-related gene signatures in bladder cancer","volume":"162","author":"Xu","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.tice.2024.102679_bib134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-018-0540-0","article-title":"LncRNA XIST\/miR-200c regulates the stemness properties and tumourigenicity of human bladder cancer stem cell-like cells","volume":"18","author":"Xu","year":"2018","journal-title":"Cancer Cell Int."},{"issue":"3","key":"10.1016\/j.tice.2024.102679_bib135","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003416","article-title":"Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer","volume":"10","author":"Xu","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.tice.2024.102679_bib136","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004569","article-title":"NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer","volume":"10","author":"Yan","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"24","key":"10.1016\/j.tice.2024.102679_bib137","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.16386","article-title":"Accumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancer","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.tice.2024.102679_bib138","doi-asserted-by":"crossref","first-page":"9377","DOI":"10.1080\/21655979.2021.1974645","article-title":"CRTAC1 (Cartilage acidic protein 1) inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process in bladder cancer by downregulating Yin Yang 1 (YY1) to inactivate the TGF-\u03b2 pathway","volume":"12","author":"Yang","year":"2021","journal-title":"Bioengineered"},{"issue":"3","key":"10.1016\/j.tice.2024.102679_bib139","article-title":"Fibroblast ER\u03b1 promotes bladder cancer invasion via increasing the CCL1 and IL-6 signals in the tumor microenvironment","volume":"5","author":"Yeh","year":"2015","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.tice.2024.102679_bib140","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s12672-024-00982-6","article-title":"CXCL10 could be a prognostic and immunological biomarker in bladder cancer","volume":"15","author":"Yin","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.tice.2024.102679_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111892","article-title":"The quantity, function and anti-tumor effect of Mucosal associated invariant T cells in patients with bladder cancer","volume":"133","author":"Zhang","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"15","key":"10.1016\/j.tice.2024.102679_bib142","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1038\/onc.2016.367","article-title":"CXCL2\/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer","volume":"36","author":"Zhang","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.tice.2024.102679_bib143","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.786728","article-title":"TGF-\u03b2 signaling and resistance to cancer therapy","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"11","key":"10.1016\/j.tice.2024.102679_bib144","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/tox.23331","article-title":"MiR-186-5p suppresses cell migration, invasion, and epithelial mesenchymal transition in bladder cancer by targeting RAB27A\/B","volume":"36","author":"Zhang","year":"2021","journal-title":"Environ. Toxicol."},{"issue":"11","key":"10.1016\/j.tice.2024.102679_bib145","article-title":"ETV4 mediated tumor-associated neutrophil infiltration facilitates lymphangiogenesis and lymphatic metastasis of bladder cancer","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.tice.2024.102679_bib146","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.gene.2019.04.039","article-title":"NF-\u03baB inhibitor, BAY11-7082, suppresses M2 tumor-associated macrophage induced EMT potential via miR-30a\/NF-\u03baB\/Snail signaling in bladder cancer cells","volume":"710","author":"Zhang","year":"2019","journal-title":"Gene"},{"issue":"55","key":"10.1016\/j.tice.2024.102679_bib147","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.21400","article-title":"Enhancing E-cadherin expression via promoter-targeted miR-373 suppresses bladder cancer cells growth and metastasis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.tice.2024.102679_bib148","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.yexcr.2018.09.013","article-title":"The functional potency of natural killer cells in response to IL-2\/IL-15\/IL-21 stimulation is limited by a concurrent upregulation of Tim-3 in bladder cancer","volume":"372","author":"Zhang","year":"2018","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.tice.2024.102679_bib149","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3892\/or.2020.7852","article-title":"lncRNA CASC9 sponges miR-758-3p to promote proliferation and EMT in bladder cancer by upregulating TGF-\u03b22","volume":"45","author":"Zhang","year":"2021","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.tice.2024.102679_bib150","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s11255-022-03173-w","article-title":"Cigarette smoking and risk of bladder cancer: a dose\u2013response meta-analysis","volume":"54","author":"Zhao","year":"2022","journal-title":"Int. Urol. Nephrol."},{"issue":"30","key":"10.1016\/j.tice.2024.102679_bib151","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202303473","article-title":"LncRNA BCCE4 genetically enhances the PD-L1\/PD-1 interaction in smoking-related bladder cancer by modulating miR-328-3p-USP18 signaling","volume":"10","author":"Zheng","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.tice.2024.102679_bib152","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.omtm.2021.05.010","article-title":"Unique somatic variants in DNA from urine exosomes of individuals with bladder cancer","volume":"22","author":"Zhou","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"3","key":"10.1016\/j.tice.2024.102679_bib153","first-page":"3403","article-title":"Increased expression of TNFRSF14 indicates good prognosis and inhibits bladder cancer proliferation by promoting apoptosis","volume":"18","author":"Zhu","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"10","key":"10.1016\/j.tice.2024.102679_bib154","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/0008-5472.CAN-22-2213","article-title":"Cancer-associated fibroblast\u2013derived miR-146a-5p generates a niche that promotes bladder cancer stemness and chemoresistance","volume":"83","author":"Zhuang","year":"2023","journal-title":"Cancer Res."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004081662400380X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004081662400380X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T23:35:27Z","timestamp":1740785727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004081662400380X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":154,"alternative-id":["S004081662400380X"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2024.102679","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterogeneity of modulatory immune microenvironment in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2024.102679","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102679"}}